공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

COVID-19 관련 임상시험, 원격의료, 백신 및 기타 시장(개정판)

COVID-19 Update, Clinical Testing, Telehealth, Vaccines and Other Markets

리서치사 Kalorama Information
발행일 2020년 11월 상품 코드 984999
페이지 정보 영문
가격
US $ 4,000 ₩ 4,524,000 Single User (Online Access)
US $ 6,000 ₩ 6,787,000 Ten Users (Online Access & PDF Download)
US $ 8,000 ₩ 9,049,000 Unlimited Users (Online Access & PDF Download)


COVID-19 관련 임상시험, 원격의료, 백신 및 기타 시장(개정판) COVID-19 Update, Clinical Testing, Telehealth, Vaccines and Other Markets
발행일 : 2020년 11월 페이지 정보 : 영문

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

COVID-19 관련 임상시험, 원격의료, 백신 및 기타 시장의 최신 정보를 조사했으며, 시장 개요, 분자진단·항원 및 항체 검사·백신 등의 시장 변화, 유형·지역별 분석 등의 정보를 정리하여 전해드립니다.

목차

제1장 개요

  • 개요
    • COVID-19 사례 합계
    • 주요 국가별 : COVID의 7일간 평균 증례 수(백만 명당) 추이
    • COVID-19 테스트
  • 범위와 방법

제2장 COVD-19 진단

  • 임상 검사 상황
    • 다수의 승인
  • FDA에 의해 승인된 검사
    • 분자
    • 면역학적 검사
  • COVID-19 상황을 바꾸는 항원 검출 검사
    • COVID-19 시장
  • COVID-19 테스트 개발
    • LDT 시장을 좌우하는 COVID-19
    • 응급의료 센터와 COVID-19 검사
    • 다양한 SARS-CoV-2 항체 키트의 정도
    • COVID-19 'Nudge' 검사의 임상 연구에서의 유망성
    • 고감도의 새로운 CRISPR 기반 COVID-19 검사 등
  • 제품 개발
    • NIH, BARDA : COVID-19 계약에 의한 9,835만 달러의 수여
    • 새로운 COVIDNGS 검사
    • Cue : COVID-19 테스트를 위한 DOD 그랜트의 확보
    • Beckman Coulter : COVID-19 IgM 어세이
    • GenMark : 멀티플렉스 테스트 등
  • 새로운 입법
    • COVID-19 테스트에 중요한 LDT, AACC

제3장 원격의료

  • COVID-19가 원격의료에 미치는 영향
    • COVID-19의 요점
    • RPM/원격의료 시장의 실적
  • 기업의 실적
    • ABBOTT
    • AMERICAN WELL(AMWELL)
    • ASCOM HOLDING AG
    • BRIGHT.MD
    • DOCTOR ON DEMAND
    • EKO DEVICES
    • G MEDICAL INNOVATIONS HOLDING LTD.
    • GENERAL DEVICES
    • GLOOKO
    • MASIMO
    • MEDTRONIC
    • OSI SYSTEMS
    • PHILIPS - KONINKLIJKE PHILIPS N.V.(ROYAL PHILIPS)
    • TELADOC HEALTH
    • THINKLABS
    • TYTOCARE

제4장 COVID-19와 생명과학 조사

  • 조사실 셧다운과 현황의 거부
  • COVID-19의 조사와 출판물
  • COVID-19 치료법 개발을 위한 조사 항체
  • 생명과학 툴 시장의 고려사항

제5장 백신

  • 미국의 성인은 COVID-19 백신을 어떻게 수용하는가?
  • 유니버설 코로나바이러스 백신?
    • Moderna : 중동·아프리카로부터의 찬동 및 판매 승인의 제출
KSA 21.02.17

COVID-19 continues to be a dominant issue for healthcare systems worldwide and in the United States. Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic.

Particular sections address the most important market changes:

  • Molecular Diagnostics: COVID-19 has seen the molecular in vitro diagnostics (IVD) industry bring out its best efforts in terms of fast test RT-PCR tests for their systems, point of care solutions, syndromic tests, high throughput systems and surge production on badly needed kits.
  • Antigen and Antibody Tests: Never have immunoassays been of such worldwide attention, as antibody tests are greatly sought. With this, come concerns about accuracy levels on broad populations and greater knowledge about development times. There are now immunoassays in development. We track these efforts and provide commentary on the role of these tests in a threat so far dominated by molecular diagnostics.
  • Vaccines: We look at the vaccines in development and the struggles with vaccine discovery and manufacturing in other pandemics.
  • Life Science Research - what are the trends in experiments and publications, how has COVID-19 affected lab research volume and tools markets.
  • Remote Patient Monitoring: Already a healthcare trend that was catching on but perhaps struggling to convince payors of its critical necessity, remote patient monitoring and telehealth transformed overnight with social distancing policies and relaxed HIPAA rules. Kalorama has contacted a number of companies for October 2020 updates.

As part of this report's offerings, the following information is included:

  • Market for COVID-19 by Type: PCR, Antigen, Antibody
  • Market for COVID-19 by Region: US, Europe, Asia, ROW
  • Current EUA Test Approvals
  • Antigen COVID-19 Tests
  • Overall Clinical Lab Volume Trends (April to September)
  • Market for Telehealth and COVID-19 Impact
  • Telehealth Company Responses to COVID-19
  • COVID-19 Vaccines in Development
  • COVID-19 Vaccine Pre Sales

This report does not seek to provide a data-driven market assessment due to the rapidly-changing situation, but does provide analyst commentary that may assist customers needing to work out models. Some of Kalorama Information's market estimates provide foundational bases on which to judge potential market impact.

Commentary and analysis from Kalorama authors who have studied markets in some cases for decades add understanding to the current, often chaotic, market atmosphere. Further publications and surveys from Kalorama Information will provide additional market impact data.

Companies Discussed Include:

  • Abbott
  • American Well (Amwell)
  • Ascom Holding
  • Astra Zeneca
  • Beckman Coulter
  • Becton Dickinson
  • Bright.Md
  • Cepheid
  • Cue Health
  • Doctor On Demand
  • Eko Devices
  • Eurofins
  • G Medical Innovations Holding Ltd.
  • General Devices
  • Genmark
  • Hologic
  • Johnson and Johnson
  • Medtronic
  • Moderna
  • Philips
  • Qiagen
  • Quidel
  • Roche
  • Teladoc Health

TABLE OF CONTENTS

CHAPTER 1: EXECUTIVE SUMMARY

  • OVERVIEW
    • COVID-19 Cases Total
    • COVID Cases Rolling 7-Day Average Per Million by Major Countries
    • COVID-19 TESTING
  • SCOPE AND METHODOLOGY

CHAPTER 2: COVD-19 DIAGNOSTICS

  • CLINICAL LAB SITUATION
    • Table: Clinical Labs Percent of Labs Experiencing Volume Declines Due to COVID-19 and Shutdowns [Major, Minor, No Decline]
    • Large Number of Approvals
  • TEST APPROVED BY FDA
    • Molecular
    • Immunoassays
      • Table: Tests for COVID-19 Authorized by FDA
  • ANTIGENT TESTS CHANGE COVID-19 LANDSCAPE
    • COVID-19 MARKET
      • Figure : IVD COVID-19 Market, Distribution by Region (North America, Europe, Asia Pacific, RoW), 2020 % KOREAN COVID-19 TESTING FOCUS
  • COVID-19 TESTING DEVELOPMENTS
    • COVID Driving LDT Market
    • CMS Seeks to Spur Speed of Results by Cutting Fees for Slower Labs
    • Urgent care Centers and COVID-19 testing
    • Study finds SARS-CoV-2 antibody kits have varying accuracy
    • COVID-19 "Nudge" Test shows promise in clinical study
    • New CRISPR-based COVID-19 test shows high sensitivity
    • Blood test score helps predict COVID-19 severity
    • Biomarkers to determine COVID-19 odds: GW researchers
  • PRODUCT DEVELOPMENTS
    • NIH, BARDA award $98.35M in COVID-19 Contracts
    • New COVID NGS Test
    • Cue secures DOD Grant for COVID-19 tests
    • Beckman Coulter COVID-19 IgM assay
    • GenMark Multiplex test
    • 20/20 takes orders for 1st POC Fingerstick COVID-19 test
    • Quidel gets EUA for Combo flu, COVID-19 test
    • Biocept reaches COVID-19 testing milestone
    • LabCorp nabs EUA for new COVID-19 molecular test
    • FDA issues EUA for OralDNA's oral rinse COVID-19 test
    • LDTs AND COVID-19
  • NEW LEGISLATION
    • LDTs Critical for COVID-19 Testing, Says AACC

CHAPTER 3: TELEHEALTH

  • COVID-19 IMPACT ON TELEHALTH: KEY TAKEAWAYS
    • COVID-19 Key Takeaways
    • RPM/Telehealth Market Performance
  • COMPANY RESULTS
    • ABBOTT
    • AMERICAN WELL (AMWELL)
    • ASCOM HOLDING AG
    • BRIGHT.MD
    • DOCTOR ON DEMAND
    • EKO DEVICES
    • G MEDICAL INNOVATIONS HOLDING LTD.
    • GENERAL DEVICES
    • GLOOKO
    • MASIMO
    • MEDTRONIC
    • OSI SYSTEMS
    • PHILIPS - KONINKLIJKE PHILIPS N.V. (ROYAL PHILIPS)
    • TELADOC HEALTH
    • THINKLABS
    • TYTOCARE

CHAPTER 4. COVID-19 AND LIFE SCIENCE RESEARCH

  • RESEARCH LAB SHUTDOWN AND DECLINE STATUS
  • COVID-19 RESEARCH AND PUBLICATIONS
  • SHINING A SPOTLIGHT IN A CHALLENGED MARKET: RESEARCH ANTIBODIES FOR COVID-19 THERAPEUTIC DEVELOPMENT
  • LIFE SCIENCE TOOLS MARKET CONSIDERATIONS

CHAPTER 5. VACCINES

  • Figure: COVID-19 Per Capita Doses Ordered by Country
  • Figure: COVID-19 Vaccine Candidates: Government Presales
  • HOW WILLING ARE U.S. ADULTS TO ACCEPT A COVID-19 VACCINE?
  • UNIVERSAL CORONAVIRUS VACCINES?
    • Moderna gets nod from EMA to submit marketing authorization
Back to Top
전화 문의
F A Q